HSOA Stock Overview
Provides post-acute healthcare services in the United States and Puerto Rico.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Encompass Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$86.50 |
| 52 Week High | US$86.50 |
| 52 Week Low | US$56.50 |
| Beta | 0.78 |
| 11 Month Change | 5.49% |
| 3 Month Change | 9.49% |
| 1 Year Change | 37.30% |
| 33 Year Change | 34.11% |
| 5 Year Change | 53.10% |
| Change since IPO | 267.60% |
Recent News & Updates
Recent updates
Shareholder Returns
| HSOA | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 6.1% | 2.3% | 4.5% |
| 1Y | 37.3% | 5.9% | 13.4% |
Return vs Industry: HSOA exceeded the German Healthcare industry which returned 5.9% over the past year.
Return vs Market: HSOA exceeded the German Market which returned 13.4% over the past year.
Price Volatility
| HSOA volatility | |
|---|---|
| HSOA Average Weekly Movement | 3.0% |
| Healthcare Industry Average Movement | 3.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.6% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: HSOA has not had significant price volatility in the past 3 months.
Volatility Over Time: HSOA's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 27,253 | Mark Tarr | www.encompasshealth.com |
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Encompass Health Corporation Fundamentals Summary
| HSOA fundamental statistics | |
|---|---|
| Market cap | €8.65b |
| Earnings (TTM) | €366.30m |
| Revenue (TTM) | €4.54b |
23.6x
P/E Ratio1.9x
P/S RatioIs HSOA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HSOA income statement (TTM) | |
|---|---|
| Revenue | US$5.07b |
| Cost of Revenue | US$2.98b |
| Gross Profit | US$2.10b |
| Other Expenses | US$1.69b |
| Earnings | US$409.00m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.06 |
| Gross Margin | 41.32% |
| Net Profit Margin | 8.07% |
| Debt/Equity Ratio | 94.4% |
How did HSOA perform over the long term?
See historical performance and comparisonDividends
0.7%
Current Dividend Yield15%
Payout RatioDoes HSOA pay a reliable dividends?
See HSOA dividend history and benchmarks| Encompass Health dividend dates | |
|---|---|
| Ex Dividend Date | Oct 01 2024 |
| Dividend Pay Date | Oct 15 2024 |
| Days until Ex dividend | 1 day |
| Days until Dividend pay date | 15 days |
Does HSOA pay a reliable dividends?
See HSOA dividend history and benchmarks